| BIOMARKER INFORMATION | |
|---|---|
Biomarker |
Amyloid Beta Peptide |
Category |
Molecular Changes |
Affected targets |
Brain Aging |
Hallmarks |
Loss of Proteostasis |
Molecular |
Protein |
Description |
Amyloid deposition is a primary predictor of Alzheimer's disease (AD) and related neurodegenerative disorders. |
| EXPERIMENT INFORMATION | |
Region |
USA |
Race |
multiple racial |
Samples |
57 |
Age |
66.7±3.4/66.6±4.4 |
Gender |
32/25 |
Application |
Predictive |
Conclusion |
Verp may assist in the early detection of amyloid deposition among older individuals without observable neurocognitive impairments and in linking previously documented retinal deficits in both prodromal ad and mci to behavioral impairments in social cognition. |
Reference |
Daniel C. Javitt, Alzheimer's Research & Therapy, 2023 |
Details |
PMID:36855162 (Click to Pubmed) ； IF: ； Citation: |
Confidence |